3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neuroendocrine Tumors
1
Myeloproliferative Disorders
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
Mitotane
4
Cisplatin
3
pembrolizumab
2
cixutumumab
2
Etoposide
2
Doxorubicin
2
Dichlorodiphenyldichloroethane
2
sodium thiosulfate
1
relacorilant
1
pegfilgrastim
1
milademetan
1
gossypol acetic acid
1
cabozantinib
1
avelumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Sunitinib
1
Streptozocin
1
Platinum
1
Nivolumab
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Fentanyl
1
Ethane
1
Cytoreduction Surgical Procedures
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adrenocortical Carcinoma
×
entinostat
×
Clear all
No trials found.